Cargando…
Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study
BACKGROUND: Patients with Parkinson’s disease (PD) can develop impulse control disorders (ICDs) while undergoing a pharmacological treatment for motor control dysfunctions with a dopamine agonist (DA). Conventional clinical interviews or questionnaires can be biased and may not accurately diagnose a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252252/ https://www.ncbi.nlm.nih.gov/pubmed/34215283 http://dx.doi.org/10.1186/s12984-021-00897-1 |
_version_ | 1783717261145538560 |
---|---|
author | Lin, Yuan-Pin Liang, Hsing-Yi Chen, Yueh-Sheng Lu, Cheng-Hsien Wu, Yih-Ru Chang, Yung-Yee Lin, Wei-Che |
author_facet | Lin, Yuan-Pin Liang, Hsing-Yi Chen, Yueh-Sheng Lu, Cheng-Hsien Wu, Yih-Ru Chang, Yung-Yee Lin, Wei-Che |
author_sort | Lin, Yuan-Pin |
collection | PubMed |
description | BACKGROUND: Patients with Parkinson’s disease (PD) can develop impulse control disorders (ICDs) while undergoing a pharmacological treatment for motor control dysfunctions with a dopamine agonist (DA). Conventional clinical interviews or questionnaires can be biased and may not accurately diagnose at the early stage. A wearable electroencephalogram (EEG)-sensing headset paired with an examination procedure can be a potential user-friendly method to explore ICD-related signatures that can detect its early signs and progression by reflecting brain activity. METHODS: A stereotypical Go/NoGo test that targets impulse inhibition was performed on 59 individuals, including healthy controls, patients with PD, and patients with PD diagnosed by ICDs. We conducted two Go/NoGo sessions before and after the DA-pharmacological treatment for the PD and ICD groups. A low-cost LEGO-like EEG headset was used to record concurrent EEG signals. Then, we used the event-related potential (ERP) analytical framework to explore ICD-related EEG abnormalities after DA treatment. RESULTS: After the DA treatment, only the ICD-diagnosed PD patients made more behavioral errors and tended to exhibit the deterioration for the NoGo N2 and P3 peak amplitudes at fronto-central electrodes in contrast to the HC and PD groups. Particularly, the extent of the diminished NoGo-N2 amplitude was prone to be modulated by the ICD scores at Fz with marginal statistical significance (r = − 0.34, p = 0.07). CONCLUSIONS: The low-cost LEGO-like EEG headset successfully captured ERP waveforms and objectively assessed ICD in patients with PD undergoing DA treatment. This objective neuro-evidence could provide complementary information to conventional clinical scales used to diagnose ICD adverse effects. |
format | Online Article Text |
id | pubmed-8252252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82522522021-07-06 Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study Lin, Yuan-Pin Liang, Hsing-Yi Chen, Yueh-Sheng Lu, Cheng-Hsien Wu, Yih-Ru Chang, Yung-Yee Lin, Wei-Che J Neuroeng Rehabil Research BACKGROUND: Patients with Parkinson’s disease (PD) can develop impulse control disorders (ICDs) while undergoing a pharmacological treatment for motor control dysfunctions with a dopamine agonist (DA). Conventional clinical interviews or questionnaires can be biased and may not accurately diagnose at the early stage. A wearable electroencephalogram (EEG)-sensing headset paired with an examination procedure can be a potential user-friendly method to explore ICD-related signatures that can detect its early signs and progression by reflecting brain activity. METHODS: A stereotypical Go/NoGo test that targets impulse inhibition was performed on 59 individuals, including healthy controls, patients with PD, and patients with PD diagnosed by ICDs. We conducted two Go/NoGo sessions before and after the DA-pharmacological treatment for the PD and ICD groups. A low-cost LEGO-like EEG headset was used to record concurrent EEG signals. Then, we used the event-related potential (ERP) analytical framework to explore ICD-related EEG abnormalities after DA treatment. RESULTS: After the DA treatment, only the ICD-diagnosed PD patients made more behavioral errors and tended to exhibit the deterioration for the NoGo N2 and P3 peak amplitudes at fronto-central electrodes in contrast to the HC and PD groups. Particularly, the extent of the diminished NoGo-N2 amplitude was prone to be modulated by the ICD scores at Fz with marginal statistical significance (r = − 0.34, p = 0.07). CONCLUSIONS: The low-cost LEGO-like EEG headset successfully captured ERP waveforms and objectively assessed ICD in patients with PD undergoing DA treatment. This objective neuro-evidence could provide complementary information to conventional clinical scales used to diagnose ICD adverse effects. BioMed Central 2021-07-02 /pmc/articles/PMC8252252/ /pubmed/34215283 http://dx.doi.org/10.1186/s12984-021-00897-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lin, Yuan-Pin Liang, Hsing-Yi Chen, Yueh-Sheng Lu, Cheng-Hsien Wu, Yih-Ru Chang, Yung-Yee Lin, Wei-Che Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study |
title | Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study |
title_full | Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study |
title_fullStr | Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study |
title_full_unstemmed | Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study |
title_short | Objective assessment of impulse control disorder in patients with Parkinson’s disease using a low-cost LEGO-like EEG headset: a feasibility study |
title_sort | objective assessment of impulse control disorder in patients with parkinson’s disease using a low-cost lego-like eeg headset: a feasibility study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252252/ https://www.ncbi.nlm.nih.gov/pubmed/34215283 http://dx.doi.org/10.1186/s12984-021-00897-1 |
work_keys_str_mv | AT linyuanpin objectiveassessmentofimpulsecontroldisorderinpatientswithparkinsonsdiseaseusingalowcostlegolikeeegheadsetafeasibilitystudy AT lianghsingyi objectiveassessmentofimpulsecontroldisorderinpatientswithparkinsonsdiseaseusingalowcostlegolikeeegheadsetafeasibilitystudy AT chenyuehsheng objectiveassessmentofimpulsecontroldisorderinpatientswithparkinsonsdiseaseusingalowcostlegolikeeegheadsetafeasibilitystudy AT luchenghsien objectiveassessmentofimpulsecontroldisorderinpatientswithparkinsonsdiseaseusingalowcostlegolikeeegheadsetafeasibilitystudy AT wuyihru objectiveassessmentofimpulsecontroldisorderinpatientswithparkinsonsdiseaseusingalowcostlegolikeeegheadsetafeasibilitystudy AT changyungyee objectiveassessmentofimpulsecontroldisorderinpatientswithparkinsonsdiseaseusingalowcostlegolikeeegheadsetafeasibilitystudy AT linweiche objectiveassessmentofimpulsecontroldisorderinpatientswithparkinsonsdiseaseusingalowcostlegolikeeegheadsetafeasibilitystudy |